| Literature DB >> 20300400 |
Babu Uma1, Kesani Prabhakar, Saddayappan Rajendran, Kannaiyan Kavitha, Yelavarthi Lakshmi Sarayu.
Abstract
BACKGROUND: The emergence of drug resistance among diarrheagenic Escherichia coli (E. coli) in the pediatric population is an important cause of morbidity and mortality in developing countries.Entities:
Keywords: Antibiotic sensitivity; Diarrhea; E. coli; Plasmids; Transconjugants
Year: 2009 PMID: 20300400 PMCID: PMC2840953 DOI: 10.4103/0974-777X.56255
Source DB: PubMed Journal: J Glob Infect Dis ISSN: 0974-777X
Antibiotic-resistance patterns of E. coli isolates and plasmid analysis
| Antimicrobial resistance pattern | No. of isolates (%) | No. of strains with plasmids |
|---|---|---|
| Ap, I, Co | 18 (17.14) | 11 |
| Ap, I, Co, Chl | 5 (4.76) | 5 |
| Ap, I, Co, Na | 2 (1.9) | 2 |
| Ap, I, Co, Nor | 9 (8.57) | 5 |
| Ap, I, Co, Cip | 5 (4.76) | 3 |
| Ap, I, Co, Chl, Na | 2 (1.9) | 2 |
| Ap, I, Co, Chl, Cip | 4 (3.81) | 3 |
| Ap, I, Co, Na, Ca | 5 (4.76) | 3 |
| Ap, I, Co, Cip, Nor | 6 (5.71) | 1 |
| Ap, I, Co, Cip, Ca | 8 (7.62) | 4 |
| Ap, I, Co, Na, Nor | 1 (0.95) | 1 |
| Ap, I, Co, Ca, Ci | 1 (0.95) | 1 |
| Ap, I, Co, Na, Ci | 1 (0.95) | 1 |
| Ap, I, Co, Ca, Ce | 2 (1.9) | 1 |
| Ap, I, Co, Chl, Na, Nor | 2 (1.9) | 2 |
| Ap, I, Co, Chl, Cip, Ca | 1 (0.95) | - |
| Ap, I, Co, Chl, Cip, Ce | 4 (3.81) | 3 |
| Ap, I, Co, Chl, Nor, Ce | 2 (1.9) | 2 |
| Ap, I, Co, Na, Cip, Ce | 3 (2.86) | 2 |
| Ap, I, Co, Na, Cip, Ca | 2 (1.9) | 1 |
| Ap, I, Co, Na, Ca, Ci | 3 (2.86) | 2 |
| Ap, I, Co, Na, Cip, Ci | 2 (1.9) | 2 |
| Ap, I, Co, Na, Nor, Ca | 2 (1.9) | 2 |
| Ap, I, Co, Na, Nor, Cip | 2 (1.9) | 1 |
| Ap, I, Co, Na, Ce, Ca | 1 (0.95) | 1 |
| Ap, I, Co, Nor, Cip, Ca | 3 (2.86) | 2 |
| Ap, I, Co, Cip, Ca, Ca | 2 (1.9) | - |
| Ap, I, Co, Cip, Ci, Ce | 2 (1.9) | 1 |
| Ap, I, Co, Chl, Na, Cip, Ca, Ci | 5 (4.76) | 3 |
Ap: Ampicillin, I: Imipenem, Co: Cotrimoxazole, Chl: Chloramphenicol, Cip: Ciprofloxacin, Na: Nalidixic acid, Nor: Norfloxacin, Ca: Cefotaxime, Ce: Ceftazidime, Ci: Ceftriaxone
Characteristic features of some representative strains of E. coli donors and transconjugants
| Bacterial strain no. | Resistance pattern | Plasmid size (Kb) | Transconjugants resistance pattern | Plasmid size (Kb) |
|---|---|---|---|---|
| Ap. I, Co, Na, Nor | 25, 4.8, 2.6 | Ap. I, Co | 4.8 | |
| Ap. I, Co, Nor, Cip, Ca | 4.8, 1.6, 1.2 | Ap, I, Co | 4.8 | |
| Ap. I, Co, Na, Cip, Ce | 4.8, 3.2 | Ap. I, Co | 4.8, 3.2 | |
| Ap. I, Co, Chl | - | - | - | |
| Ap. I, Co, Chl, Na | 4.8, 1.5 | Ap. I, Co | 4.8 | |
| Ap. I, Co, Na, Nor, Cip, | 4.8, 2.0, 1.7 | Ap. I, Co | 4.8, 1.7 | |
| Ap, I, Co, Na, Ca, Ci | 4.8, 1.5, 1.2 | - | - | |
| Ap. I, , Co, Nor, Na | 4.8, 1.4 | Ap, I, Co | 4.8, 1.4 | |
| Ap. I, Co, Chl, Na, Cip, Ca, Ci | 25, 4.8, 2.8 | Ap, I, Co | 4.8 | |
| Ap, I, Co, Na, Nor, Cip | 4.8, 1.2 | Ap, I, co, | 4.8 |
Ap: Ampicillin, I: Imipenem, Co: Cotrimoxazole, Chl: Chloramphenicol, Cip: Ciprofloxacin, Na: Nalidixic acid, Nor: Norfloxacin, Ca: Cefotaxime, Ce: ceftazidime, Ci: Ceftriaxone
Figure 1Plasmid profiles of E.coli isolates and its transconjugants given in lane 1-14, M: Marker Lambda DNA digested with EcoRI and HIND III